Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emergent BioSolutions is a global life sciences company focused on providing preparedness and response solutions for public health threats. The Lansing, Michigan facility, operating as Emergent Biodefense Operations Lansing, is a critical manufacturing site responsible for the production of BioThrax, the only FDA-licensed vaccine for anthrax prevention. The company's portfolio also includes the opioid overdose reversal agent Narcan and vaccines for smallpox, cholera, and typhoid. In addition to its own product line, Emergent provides contract development and manufacturing services (CDMO) to the pharmaceutical and biotechnology industries. The Lansing site has a historical foundation as the Michigan Biologic Products Institute, which was privatized and later became the cornerstone of Emergent's biodefense operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emergent Biodefense Operations Lansing.